Physician profile
Kyle Chun
NPI 1558527408
$159,641.60
in general payments reported to CMS, 2019-2025
7 companies · $78K in 2025
The $78K reported for 2025 was more than what 96% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $11K · 2021: $11K · 2022: $7,807 · 2023: $19K · 2024: $19K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Royalty Or License: $49K · Travel and Lodging: $7,674 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,600 · Food and Beverage: $2,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,100.00 |
| Royalty Or License | $49,028.42 |
| Travel and Lodging | $7,674.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,600.00 |
| Food and Beverage | $2,406.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $154,562.63 | 2019-2025 | Arthrex, Shoulder Implants |
| Johnson & Johnson Health Care Systems INC. | $1,502.90 | 2021 | |
| Impactortho, INC. | $1,254.98 | 2022-2025 | |
| Sportstek Medical, INC | $1,152.00 | 2019 | |
| Bioventus LLC | $1,134.02 | 2021-2023 | Durolane |
| Baudax Bio INC. | $18.74 | 2021 | |
| Vericel Corporation | $16.33 | 2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Chun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.